Beta2-adrenoreceptor agonists and long-term risk of Parkinson's disease.
Tuominen JA, Bjørnevik K, Romanowska J, Solheim MH, Grydeland TB, Cortese M, Scherzer CR, Riise T, Igland J.
Tuominen JA, et al.
Parkinsonism Relat Disord. 2023 May;110:105389. doi: 10.1016/j.parkreldis.2023.105389. Epub 2023 Mar 31.
Parkinsonism Relat Disord. 2023.
PMID: 37027994
Free PMC article.